Raxibacumab 返回列表頁

僅用于工業(yè)應(yīng)用或科學(xué)研究，不可用于人類或動物的臨床診斷或治療，非藥用. Raxibacumab （ABthrax） is a human IgG1 monoclonal antibody against Bacillus anthracis protective antigen （PA）. Raxibacumab blocks the toxin’s deleterious effects by preventing binding of the protective antigen component of the anthrax toxin to its receptors in host cells, thereby blocking the toxin’s deleterious effects. Raxibacumab can be used for anti-anthrax research